Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
Paragon Bioservices
Paragon Bioservices
Activities:
Manufacturing
Pharmaceutical
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Graphs and graph data science in drug discovery
Life sciences data expert Dr Alexander Jarasch discusses what work being done at the Institut de Recherches Servier can teach us about using modern data technologies for early...
Why smaller CDMOs should enhance their operational efficiency now: a CPHI expert guide
CPHI experts advise smaller CDMO's to invest in supply chain resilience, friend shoring and AI to keep up with the predicted uptick in funding for 2025
CPI collaborates with industry leaders to expedite drug manufacturing via digitisation
Digitising manufacturing technologies could allow enhanced ability to scale production, reduce costs and expedite the process
Janssen to adopt Johnson & Johnson brand as the company celebrates 100 years of UK operation
The company's pharmaceutical and medical technology segments will combine under the Johnson & Johnson brand name in the UK
Upcoming event
ASGCT Annual Meeting 2024
7-11 May, 2024 | Meeting | Portland, OR
See all
Related Content
Finance
Catalent makes all-cash purchase of Paragon Bioservices
The CDMO will spend US$1.2 billion to purchase the viral vector producer, with further investment spent on capital expansion projects already underway
Pharmaceutical
Paragon Bioservices appoints Bill Thomas as Chief Technology Officer
Vaccines industry veteran was most recently with MassBiologics
Manufacturing
Paragon Bioservices hires new VP of Quality
Experienced microbiologist Carolyn Phillips joins the US CDMO
Manufacturing
Paragon Bioservices wins US$15m filovirus vaccine contract
Awarded by the US Department of Defense
Subscribe now